The Latest Cardiac and Vascular News
Viz.ai One and Precision Imaging Network simplify healthcare organization access to a comprehensive collection of diagnostic imaging AI models and end-to-end care coordination November 27, 2024 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Microsoft […]
The investment, led by Avidity Partners, will enable the company to scale rapidly and ensure customer success amid tremendous growth. SAN FRANCISCO, Nov. 26, 2024 /PRNewswire/ — Sirona Medical, a pioneer in cloud-native radiology workflow software, announces $42 million in Series C…
ST. LOUIS, Nov. 26, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 36th Annual Healthcare Conference.
BURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in December.
OAKLAND, Calif., Nov. 25, 2024 /PRNewswire/ — Koya Medical, a leading medical device company pioneering solutions in vascular care, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 4:50 pm ET. Koya CEO, Andy…
Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, Nov. 19, 2024 /PRNewswire/ — Medtronic plc (NYSE: MDT) today…
– Reported Q3 and nine-month revenues of $7.3 million and $21.2 million respectively, up 42% and 66% year-over-year – Provided 2025 guidance with expectations of over 50% annual sales growth, 20%+ reduction in operating expenses, positive full-year EBITDA, and positive cash flow in H2 2025 – Launched TriNav® LV Infusion System […]
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has included AI-ECG technology in the 2025 Hospital Outpatient Prospective Payment System (OPPS) final rule under assignment APC 5734. This approval would allow outpatient settings to receive reimbursement for HeartSciences’ MyoVista® wavECGTM algorithm and MyoVista® InsightsTM low ejection fraction algorithm, upon FDA clearance. The payment rate is expected to be $125.
Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results
